在中国接受移植患者的样本中进行系统审查和外部评估.
在PubMed上查看摘要
概括
此摘要是机器生成的。已发表的甲 (MPS) 群体药动力学 (popPK) 模型显示移植患者的预测性能较差. 外部验证发现了局限性,强调需要治疗药物监测 (TDM) 和对个性化MPS剂量共变量的进一步研究.
科学领域
- 药理学
- 肝脏病学
- 临床药房
背景情况
- 免疫抑制治疗对于预防移植的排斥至关重要.
- 甲 (MPS) 是一种关键的免疫抑制剂,已经开发了几种种群体药动力学 (popPK) 模型.
- 现有的MPS popPK模型在不同临床环境中的预测准确性尚未得到充分证实.
研究的目的
- 系统评估和外部验证已发布的MPS popPK模型.
- 评估这些模型在真实世界移植患者队列中的推断潜力.
- 确定当前模型是否适用于指导临床MPS治疗.
主要方法
- 在PubMed,Embase和Web of Science进行了系统的文献搜索,以确定相关的MPS popPK模型.
- 在青岛大学附属医院建立了一个接受MPS治疗的移植患者的外部验证队列.
- 模型的性能使用适合性,预测错误测试和视觉预测检查进行了评估.
主要成果
- 使用31名患者的186个药物度数据,评估了四个已发表的模型 (一个1区,三个2区).
- 所有模型都表现出较差的人口预测性能.
- 模型1显示相对较好的个人预测和视觉预测检查结果,而其他模型显示观察和模拟数据之间的显著偏差.
结论
- 目前已发表的MPS popPK模型显示移植患者的可观变异性和不充分的预测性能.
- 在临床实践中,治疗药物监测 (TDM) 对于优化MPS治疗至关重要.
- 未来的研究应侧重于确定关键的共变量,以便为特定患者群体开发更准确和个性化的MPS popPK模型.
相关概念视频
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

